31 – 45 of 87
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Risk-Adapted Treatment in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: The SWENOTECA Management Program.
(
- Contribution to journal › Article
-
Mark
Hypogonadism Risk in Men Treated for Childhood Cancer.
(
- Contribution to journal › Article
-
Mark
Sexual Function in Men Treated for Testicular Cancer.
(
- Contribution to journal › Article
-
Mark
Sperm DNA integrity in cancer patients : the effect of disease and treatment
(
- Contribution to journal › Article
- 2008
-
Mark
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part I
(
- Contribution to journal › Scientific review
-
Mark
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
(
- Contribution to journal › Article
-
Mark
Self-reported cognitive function among testicular cancer survivors treated with chemotherapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients
(
- Contribution to journal › Article
-
Mark
European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II
(
- Contribution to journal › Scientific review
-
Mark
A Subset of CD5- Diffuse Large B-Cell Lymphomas Expresses Nuclear Cyclin D1 With Aberrations at the CCND1 Locus.
(
- Contribution to journal › Article
-
Mark
Risk factors for post-treatment hypogonadism in testicular cancer patients.
(
- Contribution to journal › Article
-
Mark
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
(
- Contribution to journal › Article
- 2007
-
Mark
Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.
(
- Contribution to journal › Article
-
Mark
Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up
(
- Contribution to journal › Article
-
Mark
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma.
(
- Contribution to journal › Article